Polyomavirus-associated nephropathy (PVAN) is an emerging cause of kidney transplant
failure affecting 1–10% of patients. As uncertainty exists regarding risk factors, diagnosis …

Polyomavirus hominis 1, better known as BK virus (BKV), infects up to 90% of the general
population. However, significant clinical manifestations are rare and limited to individuals …

The human BK polyomavirus (BKV) is the major cause of polyomavirus-associated
nephropathy (PyVAN) putting 1–15% of kidney transplant patients at risk of premature …

BK polyomavirus (BKPyV) remains a significant challenge after kidney transplantation.
International experts reviewed current evidence and updated recommendations according …

Our purposes were to determine the incidence of BK viruria, viremia or nephropathy with
tacrolimus (FK506) versus cyclosporine (CyA) and whether intensive monitoring and …

Polyomavirus BK (BKV)-associated nephropathy causes premature kidney transplant (KT)
failure. BKV viruria and viremia are biomarkers of disease progression, but associated risk …

Polyomavirus-associated nephropathy (PVAN) is a significant cause of allograft loss. The
diagnosis requires allograft biopsy, but the impact of the histological features on diagnosis …

The human polyomaviruses, BK virus and JC virus, have long been associated with serious
diseases including polyomavirus nephropathy and progressive multifocal …

More than 70% of the general population worldwide has serological evidence of exposure to
Polyomavirus hominis type 1, better known as BK virus (BKV). BKV infection typically occurs …

Background. Polyomavirus-associated nephropathy (PVAN) is an important cause of kidney
graft loss but there is no consensus on its management. This study aimed to systematically …